The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...
Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...
Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...
The 340B Drug Pricing Program (“340B Program”) space continues to be a hive of activity. While 340B stakeholders continue to litigate ongoing manufacturer contract pharmacy restrictions, states ...
The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize the federal government’s complex 340B Drug Discount Program. SARASOTA, FL / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback